Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 18.40
-1.90 (-9.36%)
At close: Mar 27, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 93.32 million as of March 27, 2026. Its market cap has decreased by -28.60% in one year.
Market Cap
93.32M
Enterprise Value
135.66M
Revenue
176.65M
Ranking
n/a
PE Ratio
661.84
Stock Price
18.40
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 93.32M, an increase of 2,426.02%. That is a compound annual growth rate of 16.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 93.32M | -21.37% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenith Healthcare | 149.39M |
| Norris Medicines | 127.51M |
| Cian Healthcare | 125.23M |
| Ortin Global | 121.08M |
| Emmessar Biotech & Nutrition | 120.01M |
| Shamrock Industrial Company | 115.99M |
| Colinz Laboratories | 109.53M |
| Unjha Formulations | 94.05M |